MICU Intern's survival guide sepsis: Difference between revisions

Jump to navigation Jump to search
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{CMG}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]
{{Sepsis}}
{{Sepsis}}
==Overview==
==Overview==
Line 22: Line 22:
===Source control===
===Source control===
====Source identification====
====Source identification====
* Depending on the patient's history sputum, blood, urine or other sources can be cultured. In case of unclear source, pan-culture should be done.
* Depending on the patient's history, [[sputum]], [[blood]], [[urine]] or other sources can be cultured. In certain cases in which the source is unclear, a pan-culture should be done.
* Based on the patient's history proper imaging should be initiated.
* Based on the patient's history, appropriate imaging studies should be initiated.
 
====Source management====
====Source management====
* Initiation of proper antibiotic within an hour of diagnosis.
* Initiation of proper antibiotic within an hour of diagnosis.
* Drainage in cases of an abscess should be done.
* Drainage should be initiated in cases in which an [[abscess]] is present.
 
===Resuscitation===
===Resuscitation===
====Hypotension====
====Hypotension====
* Fluids are the first line management
* Fluids are the first step in management
** Crystalloids like normal saline, ringer lactate are the first to be used.
** Crystalloids such as [[normal saline]] and [[Ringer's lactate]] are the first to be used.
** Normal rate of infusion is 40-60ml/kg.
** Normal rate of infusion is 40-60 ml/kg.
* If patient still hypotensive after fluid challenge plan to insert a central venous line to guide additional fluid therapy. An internal jugular and subclavian lines are preferred.
* If the patient is still hypotensive after fluid administrations, plan to insert a central venous line to guide additional fluid therapy. Internal jugular and subclavian lines are preferred.
* CVP should be checked in Q30 minutes for adequate fluid management.
* CVP should be checked in Q30 minutes for adequate fluid management.
* Target CVP are:
* Target CVP is:
** 10-12 in non-intubated patients.
** 10-12 in non-intubated patients.
** 12-15 in intubated patients.
** 12-15 in intubated patients.
* If patient still hypotensive start vasopressors.
* If the patient is still hypotensive start [[vasopressor]]s.
** Nor-epinephrine is the first line vasopressor agent.
** [[Norepinephrine]] is the first line vasopressor agent.
** Dopamine and vasopressin are second line agents
** [[Dopamine]] and [[vasopressin]] are second line agents.
** Goal mean arterial pressure should be 65.
** A mean arterial pressure of 65 is the goal.
** Continue to bolus for CVP.
** Continue to check the CVP.
* If patient still hypotensive check ScvO2
* If the patient is still hypotensive, check ScvO2
** ScvO2 is a marker of cardiac output and tissue perfusion.
** ScvO2 is a marker of [[cardiac output]] and tissue perfusion.
** ScvO2 is a marker of cardiac output and tissue perfusion.
** Target ScvO2 is > 70%
** Target ScvO2 is > 70%
** If ScvO2 is < 70% consider transfusing with aim hematocrit of 30
** If ScvO2 is < 70% consider transfusing with aim hematocrit of 30
** If hematocrit already 30% consider starting dobutamine
** If [[hematocrit]] is already 30% consider starting [[dobutamine]].
 
** A ScvO2 of 70% indicates that the tissues are adequately extracting oxygen. Therefore, the blood returning to the heart has a low oxygen saturation level.
===Resuscitation===
** A ScvO2 of 80-85%, however, is an ominous sign. It indicates that the tissues are not adequately using oxygen and are currently producing energy anaerobically. In these situations, [[lactate]] levels in the blood start increasing.


==References==
==References==

Latest revision as of 16:58, 27 December 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]

Sepsis Microchapters

Home

Patient Information (Adult)

Patient Information (Neonatal)

Overview

Pathophysiology

Causes

Differentiating Sepsis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MICU Intern's survival guide sepsis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MICU Intern's survival guide sepsis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on MICU Intern's survival guide sepsis

CDC on MICU Intern's survival guide sepsis

MICU Intern's survival guide sepsis in the news

Blogs on MICU Intern's survival guide sepsis

Directions to Hospitals Treating Sepsis

Risk calculators and risk factors for MICU Intern's survival guide sepsis

Overview

Systemic Inflammatory Response Syndrome [1] [2]

  • SIRS can be diagnosed when two or more of the following are present:[3]
    • Heart rate > 90 beats per minute
    • Temperature < 36 (96.8 °F) or > 38 °C (100.4 °F)
    • Tachypnea > 20 breaths per minute or, on blood gas, a PaCO2 < 32 mm Hg
    • White blood cell count < 4000 cells/mm³ or > 12000 cells/mm³ (< 4 x 109 or > 12 x 109 cells/L), or > 10% band forms (immature white blood cells / bandemia).
  • SIRS can be seen in non infectious conditions like pancreatitis and myocardial infarction.

Sepsis

  • SIRS + Source of infection

Severe sepsis

  • Sepsis + organ dysfunction
  • Organ damage can present as decreased urine output, acute kidney injury, and elevated liver function tests.

Septic shock

  • Severe sepsis + persistent hypotension after adequate fluid challenge.

Multiple organ dysfunctions (MODS)

  • Progressive multiple organ failure secondary to severe sepsis.

Sepsis management

Source control

Source identification

  • Depending on the patient's history, sputum, blood, urine or other sources can be cultured. In certain cases in which the source is unclear, a pan-culture should be done.
  • Based on the patient's history, appropriate imaging studies should be initiated.

Source management

  • Initiation of proper antibiotic within an hour of diagnosis.
  • Drainage should be initiated in cases in which an abscess is present.

Resuscitation

Hypotension

  • Fluids are the first step in management
  • If the patient is still hypotensive after fluid administrations, plan to insert a central venous line to guide additional fluid therapy. Internal jugular and subclavian lines are preferred.
  • CVP should be checked in Q30 minutes for adequate fluid management.
  • Target CVP is:
    • 10-12 in non-intubated patients.
    • 12-15 in intubated patients.
  • If the patient is still hypotensive start vasopressors.
    • Norepinephrine is the first line vasopressor agent.
    • Dopamine and vasopressin are second line agents.
    • A mean arterial pressure of 65 is the goal.
    • Continue to check the CVP.
  • If the patient is still hypotensive, check ScvO2
    • ScvO2 is a marker of cardiac output and tissue perfusion.
    • Target ScvO2 is > 70%
    • If ScvO2 is < 70% consider transfusing with aim hematocrit of 30
    • If hematocrit is already 30% consider starting dobutamine.
    • A ScvO2 of 70% indicates that the tissues are adequately extracting oxygen. Therefore, the blood returning to the heart has a low oxygen saturation level.
    • A ScvO2 of 80-85%, however, is an ominous sign. It indicates that the tissues are not adequately using oxygen and are currently producing energy anaerobically. In these situations, lactate levels in the blood start increasing.

References

  1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008). "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008". Critical Care Medicine. 36 (1): 296–327. doi:10.1097/01.CCM.0000298158.12101.41. PMID 18158437. Retrieved 2012-09-16. Unknown parameter |month= ignored (help)
  2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644-55. PMID 1303622.
  3. Tslotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit. 2005 Mar;11(3):RA76-85. PMID 15735579. Full Text.

Template:WH Template:WS